To our knowledge, this study is the first investigation of genetic association between variants in XRCC1 (194Arg/Trp and 399Arg/Gln) and the risk of acute skin reaction and mucosa toxicity in NPC patients treated with RT. Here, XRCC1 is linked to skin reaction.